by admin | Aug 15, 2025 | News & Opinions
By Jonathan Wosen – Stat – But optimism pokes through, as VC returns and local biotech stocks have fared well Ever since Vince Kato was laid off, he has felt like he was just two to three months away from landing a new position. But more than a year later,...
by admin | Aug 14, 2025 | News & Opinions
By Josh Nathan-Kazis – Barron’s – Biotech investors seemed to be taking the sudden departure of a top Food and Drug Administration official last month as a good sign for the sector, but increasing turmoil at the FDA could worsen the picture for...
by admin | Aug 13, 2025 | News & Opinions
By Siladitya Ray – Forbes – Health and Human Services Secretary Robert F. Kennedy Jr. announced he is cancelling contracts and grants worth nearly $500 million earmarked to develop mRNA vaccines, as the long-time vaccine critic has repeatedly cast doubts...
by admin | Aug 12, 2025 | News & Opinions
by Brittany Cordeiro – Mayo Clinic – ROCHESTER, Minn. — Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial. The medicine used in this...
by admin | Aug 11, 2025 | News & Opinions
By Bobby Mukkamala, MD – AMA – For more than a century, NIH-sponsored research has played a critical role in improving the nation’s health. This vital work must continue. It’s not hyperbole to say my sudden brain cancer diagnosis last fall could have put a...
by admin | Aug 8, 2025 | News & Opinions
by By Kathy Liszewski – Genetic Engineering & Biology News – Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models From axolotls to zebrafish, stem cells possess remarkable regenerative...
